News Image

Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development

Provided By GlobeNewswire

Last update: Jun 17, 2025

Expanded alliance combines Lisata’s drug development expertise with GATC’s AI-powered Multiomics Advanced Technology® platform to accelerate and improve success rates of next-generation drug development

Read more at globenewswire.com

LISATA THERAPEUTICS INC

NASDAQ:LSTA (12/16/2025, 8:00:01 PM)

2.05

+0.01 (+0.49%)



Find more stocks in the Stock Screener

Follow ChartMill for more